Huang, Xiaojun <br/><br/>
Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.  [electronic resource] 

 -  Cancer research  Oct 2002 
 - 5727-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Animals<br/>Antigens, CD--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>B7-2 Antigen<br/>CD4-Positive T-Lymphocytes--drug effects<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Cancer Vaccines--immunology<br/>Combined Modality Therapy<br/>Female<br/>Immunoglobulin G--administration & dosage<br/>Indoles--administration & dosage<br/>Interferon-gamma--biosynthesis<br/>Lymphocyte Activation--drug effects<br/>Lymphocytes, Tumor-Infiltrating--drug effects<br/>Mammary Neoplasms, Experimental--blood supply<br/>Membrane Glycoproteins--administration & dosage<br/>Mice<br/>Mice, Inbred BALB C<br/>Neoplasm Metastasis<br/>Oxindoles<br/>Propionates<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrroles--administration & dosage<br/>Recombinant Fusion Proteins--administration & dosage<br/>Spleen--drug effects